TY  - GEN
AU  - Verrest, Luka
AU  - Kip, Anke E
AU  - Musa, Ahmed M
AU  - Schoone, Gerard J
AU  - Schallig, Henk DFH
AU  - Mbui, Jane
AU  - Khalil, Eltahir A G
AU  - Younis, Brima M
AU  - Olobo, Joseph
AU  - Were, Lilian
AU  - Kimutai, Robert
AU  - Monnerat, Séverine
AU  - Cruz, Israel
AU  - Wasunna, Monique
AU  - Alves, Fabiana
AU  - Dorlo, Thomas P C
PY  - 2021
DO  - 10.1093/cid/ciab124
UR  - http://hdl.handle.net/20.500.12105/14230
AB  - Background: To expedite the development of new oral treatment regimens for visceral leishmaniasis (VL), there is a need for early markers to evaluate treatment response and predict long-term outcomes. Methods: Data from 3 clinical trials were combined...
LA  - eng
PB  - Oxford University Press
KW  - Pharmacodynamics
KW  - Visceral leishmaniasis
KW  - Parasitemia
KW  - Biomarker
KW  - qPCR
KW  - Leishmaniasis, Visceral
KW  - Parasites
KW  - Africa, Eastern
KW  - Animals
KW  - Biomarkers
KW  - Humans
KW  - Parasite Load
TI  - Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern Africa
TY  - research article
ER  -